CD4+CD25+ T regulatory cells inhibit CD8+ IFN-γ production during acute and chronic FIV infection utilizing a membrane TGF-β-dependent mechanism

AIDS Research and Human Retroviruses

Volumn 26, Issue 2, 2010, Pages 201-216

  Fogle, Jonathan E ^a   Mexas, Angela M ^b   Tompkins, Wayne A ^a   Tompkins, Mary B ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL CAT; FELINE IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; IMMUNOSTIMULATION; LYMPH NODE; LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; RETROVIRUS INFECTION; T LYMPHOCYTE ACTIVATION; VIREMIA;

ANIMALS; ANTIGENS, CD4; CAT DISEASES; CATS; CD8-POSITIVE T-LYMPHOCYTES; IMMUNE TOLERANCE; IMMUNODEFICIENCY VIRUS, FELINE; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LENTIVIRUS INFECTIONS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 77149164820     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0162     Document Type: Article

References (68)

1. Tompkins MB and Tompkins WA: Lentivirus-induced immune dysregulation. Vet Immunol Immunopathol 2008; 123:45.
2. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, et al.: Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003;17:1881.
3. Davidson MG, Rottman J, English RV, Lappin MR, et al.: Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am J Pathol 1993:143:1486.
4. Dean GA, Bernales JA, and Pedersen NC: Effect of feline immunodeficiency virus on cytokine response to Listeria monocytogenes in vivo. Vet Immunol Immunopathol 1998; 65:125.
5. Burkhard MJ and Dean GA: Transmission and im-munopathogenesis of FIV in cats as a model for HIV. Curr HIV Res 2003;1:15.
6. Lopez, M, Soriano V, Lozano S, Ballesteros C, et al.: No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term non-progressors and typical progressors. AIDS Res Hum Retro-viruses 2008;24:1185.
7. Jagannathan P, Osborne CM, Royce C, Manion MM, et al.: Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, pheno-type, and interleukin-2 responsiveness. J Virol 2009;83: 2728.
8. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, et al.: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283:857.
9. Bucci J, English R, Jordan H, Childers T, et al.: Mucosally transmitted feline immunodeficiency virus induces a CD8 + antiviral response that correlates with reduction of cell-associated virus. J Infect Dis 1998;177:18.
10. + regulatory T cells in viral infections. In Regulatory T Cells and Clinical Application. Springer, New York, 2008.
11. Suvas S, Azkur AK, Kim BS, Kumaraguru U, et al.: CD4 + CD25 + regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 2004;172:4123.
12. Suvas S, Kumaraguru U, Pack CD, Lee S, et al.: CD4 + CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 2003;198:889.
13. Baumforth KR, Birgersdotter A, Reynolds GM, Wei W, et al.: Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells. Am J Pathol 2008;173:195.
14. Robertson SJ, Messer RJ, Carmody AB, and Hasenkrug KJ: In vitro suppression of CD8+ T cell function by Friend virus-induced regulatory T cells. J Immunol 2006;176:3342.
15. Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, et al.: T cells with a CD4 + CD25 + regulatory phenotype suppress in vitro proliferation of virus-specific CD8 + T cells during chronic hepatitis C virus infection. J Virol 2005;79: 7860.
16. Benito JM, Lopez M, and Soriano V: The role of CD8 + T-cell response in HIV infection. AIDS Rev 2004;6:79.
17. Collins KL: How HIV evades CTL recognition. Curr HIV Res 2003;1:31.
18. Kinter AL, Hennessey M, Bell A, Kern S, et al.: CD25 + CD4 + regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4 + and CD8 + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004;200:331.
19. Kinter AL, Horak R, Sion M, Riggin L, et al.: CD25 + regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8 + T cells in vitro. AIDS Res Hum Retroviruses 2007;23:438.
20. Vahlenkamp T, Tompkins M, and Tompkins W: Feline immunodeficiency virus (FIV) infection phenotypically and functionally activates immunosuppressive CD4 + CD25 + T regulatory (Treg) cells. J Immunol 2004;172:4752.
21. + Regulatory T cells are infected and activated during acute FIV infection. Vet Immunol Immunopathol 2008;126:263.
22. Joshi A, Vahlenkamp TW, Garg H, Tompkins WA, et al.: Preferential replication of FIV in activated CD4(+)CD25(+) T cells independent of cellular proliferation. Virology 2004;321:307.
23. von Boehmer H: Mechanisms of suppression by suppressor T cells. Nat Immunol 2005;6:338.
24. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, et al.: Cutting edge: Contact-mediated suppression by CD4 + CD25 + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005;174:1783.
25. Grossman WJ, et al.: Human T regulatory cells can use the perforin pathway to cause autologoous target cell death. Immunity 2004;21:589.
26. Read S, Greenwald R, Izcue A, Robinson N, et al.: Blockade of CTLA-4 on CD4+ CD25 + regulatory T cells abrogates their function in vivo. J Immunol 2006;177:4376.
27. Friedline RH, Brown DS, Nguyen H, Kornfeld H, et al.: CD4 + regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 2009;206:421.
28. Kataoka H, Takahashi S, Takase K, Yamasaki S, et al.: CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4. Int Immunol 2005;17:421.
29. Taylor PA, Noelle RJ, and Blazar BR: CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193:1311.
30. Paust S, McCarty N, and Cantor H: Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci USA 2004;101:10398.
31. Nakamura K, Kitani A, and Strober W: Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001;194:629.
32. Annunziato F, Cosmi L, Liotta F, Lazzeri E, et al.: Phenotype, localization, and mechanism of suppression of CD4(+) CD25(+) human thymocytes. J Exp Med 2002;196:379.
33. Oida T, Zhang X, Goto M, Hachimura S, et al.: CD4 + CD25-T cells that express latency-associated peptide on the surface suppress CD4 + CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. J Immunol 2003;170:2516.
34. Gil-Guerrero L, et al.: In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-B1. J Immunol 2008;181:126.
35. Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, et al.: CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002;196:237.
36. Kullberg MC, Hay V, Cheever AW, Mamura M, et al.: TGF-beta1 production by CD4 + CD25 + regulatory T cells is not essential for suppression of intestinal inflammation. Eur J Immunol 2005;35:2886.
37. Petty CS, Tompkins MB, and Tompkins WA: Transforming growth factor-beta/transforming growth factor-betaRII signaling may regulate CD4 + CD25 + T-regulatory cell homeostasis and suppressor function in feline AIDS lentivirus infection. J Acquir Immune Defic Syndr 2008; 47:148.
38. Lucas PJ, Kim SJ, Melby SJ, and Gress RE: Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor. J Exp Med 2000;191:1187.
39. Chen ML, Pittet MJ, Gorelik L, Flavell RA, et al.: Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA 2005;102:419.
40. Ahmadzadeh M and Rosenberg SA: TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells. J Immunol 2005;174:5215.
41. Green EA, Gorelik L, McGregor CM, Tran EH, et al.: CD4 + CD25 + T regulatory cells control anti-islet CD8 + T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA 2003;100:10878.
42. English RV, Johnson CM, Gebhard DH, and Tompkins MB: In vivo lymphocyte tropism of feline immunodeficiency virus. J Virol 1993;67:5175.
43. English RV, Nelson P, Johnson CM, Nasisse M, et al.: Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis 1994;170: 543.
44. Smithberg SR, Fogle JE, Mexas AM, Reckling SK, et al.: In vivo depletion of CD4 + CD25 + regulatory T cells in cats. J Immunol Methods 2008;329:81.
45. Tompkins MB, Gebhard DH, Bingham HR, Hamilton MJ, et al.: Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat. Vet Immunol Immunopathol 1990;26:305.
46. Winer J, Jung CK, Shackel I, and Williams PM: Development and validation of real-time quantitative reverse transcrip-tase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999;270:41.
47. Bendinelli M, Pistello M, Lombardi S, Poli A, et al.: Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev 1995;8:87.
48. Horton H, Russell N, Moore E, Frank I, et al.: Correlation between interferon - gamma secretion and cytotoxicity, in virus-specific memory T cells. J Infect Dis 2004;190:1692.
49. Nakamura K, Kitani A, Fuss I, Pedersen A, et al.: TGF-beta 1 plays an important role in the mechanism of CD4 + CD25 + regulatory T cell activity in both humans and mice. J Immunol 2004;172:834.
50. Feng XH and Derynck R: Specificity and versatility in TGF-beta signaling through Smads. Annu Rev Cell Dev Biol 2005;21:659.
51. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, et al.: HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993;341:860.
52. De Maria A, et al.: Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected childeren born to HIV-1-infected mothers. J Infect Dis 1994;170:1296.
53. Bucci J, Gebhard D, Childers T, English R, et al.: The CD8 + phenotype mediating antiviral activity in FIV-infected cats is characterized by reduced surface expression of the CD8 beta chain. J Infect Dis 1998;178:968.
54. Borrow P, Lewicki H, Hahn BH, Shaw GM, et al.: Virusspecific CD8 + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103.
55. Koup R, Safrit J, Cao Y, Andrews C, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650.
56. Schmitz JE, Simon MA, Kuroda MJ, Lifton MA, et al.: A nonhuman primate model for the selective elimination of CD8 + lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol 1999;154:1923.
57. Eggena MP, Barugahare B, Jones N, Okello M, et al.: Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005;174:4407.
58. Cumont MC, Diop O, Vaslin B, Elbim C, et al.: Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Virol 2008;82:1175.
59. Joshi A, Garg H, Tompkins MB, and Tompkins WA: Preferential feline immunodeficiency virus (FIV) infection of CD4 + CD25 + T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factors. J Virol 2005;79:4965.
60. Fernandez MA, Puttur FK, Wang YM, Howden W, et al.: T regulatory cells contribute to the attenuated primary CD8 + and CD4 + T cell responses to herpes simplex virus type 2 in neonatal mice. J Immunol 2008;180:1556.
61. Emani S: Molecular characterization of T regulatory cells in FIV infection. In Immunology. North Carolina State University, Raleigh, NC, 2006.
62. Yang GX, Lian ZX, Chuang YH, Moritoki Y, et al.: Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 2008;47:1974.
63. Leveen P, Carlsen M, Makowska A, Oddsson S, et al.: TGF-beta type II receptor-deficient thymocytes develop normally but demonstrate increased CD8 + proliferation in vivo. Blood 2005;106:4234.
64. Ocana-Morgner C, Wong KA, Lega F, Dotor J, et al.: Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection. Eur J Immunol 2007;37:1562.
65. Scott-Algara D, Buseyne F, Porrot F, Corre B, et al.: Not all tetramer binding CD8 + T cells can produce cytokines and chemokines involved in the effector functions of virus-specific CD8 + T lymphocytes in HIV-1 infected children. J Clin Immunol 2005;25:57.
66. Arrode G, Finke JS, Zebroski H, Siegal FP, et al.: CD8 + T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses. Eur J Immunol 2005;35:159.
67. Thomas DA and Massague J: TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 2005;8:369.
68. Moustakas A, Pardali K, Gaal A, and Heldin CH: Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett 2002;82:85.